CAS: 1874276-76-2

Darovasertib (LXS196) is a potent PKC inhibitor, orally active, with IC50 of 1.9 nM (PKCα), 0.4 nM (PKCθ), 3.1 μM (GSK3β).

LXS-196 is a research chemical with unique photophysical properties. It contains nitrogen atoms and has a solid composition, making it suitable for various applications. LXS-196 exhibits interesting characteristics due to the presence of an amino group and a heterocycle, which contribute to its stability and reactivity. This compound has been studied for its potential in diverse fields such as electrode development, biomass utilization, and pharmaceutical research. In electrode applications, LXS-196 has shown promise in improving conductivity and enhancing the performance of energy storage devices. Its unique structure allows for efficient charge transfer, making it an excellent candidate for use in batteries or supercapacitors. Additionally, LXS-196 has demonstrated potential in the field of biomass utilization. Its carbene moiety enables it to participate in catalytic reactions that convert biomass into valuable chemicals or fuels. This compound can play a crucial role in sustainable processes that aim to reduce reliance on fossil fuels and promote a greener future. Furthermore, LXS-196

Darovasertib